Skip to main content

Day: May 13, 2024

FlexShopper, Inc. Reports 2024 First Quarter and Year End Financial Results

BOCA RATON, Fla., May 13, 2024 (GLOBE NEWSWIRE) — FlexShopper, Inc. (Nasdaq:FPAY) (“FlexShopper”), a leading national online lease-to-own (“LTO”) retailer and payment solution provider for underserved consumers, today announced its financial results for the quarter ended March 31, 2024. Results for Quarter Ended March 31, 2024, vs. Quarter Ended March 31, 2023:Total fundings decreased 1.1% to $26.0 million from $26.3 millionTotal revenues increased 10.1% to $33.9 million from $30.8 millionGross profit increased 30.9% to $17.8 million from $13.6 millionAdjusted EBITDA1 increased by $1.2 million to $7.6 million from $6.4 millionOperating income increased 19.0% to $5.0 million from $4.2 millionNet loss attributable to common stockholders of $(1.3) million, or $(0.06) per diluted share, compared to net loss attributable...

Continue reading

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) — Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today reported financial results for the first quarter ended March 31, 2024, and provided recent business highlights. “We are excited about the therapeutic potential of our pipeline of next-generation Selected TIL therapies,” said Sammy Farah, M.B.A., Ph.D., Turnstone’s President and Chief Executive Officer. “The next frontier for TIL therapy is to extend its therapeutic activity in additional solid tumor indications beyond melanoma. Our differentiated approach includes a proprietary ‘cell selection’ step which is designed...

Continue reading

Horizon Bancorp, Inc. Names John R. Stewart, CFA as Chief Financial Officer

MICHIGAN CITY, Ind., May 13, 2024 (GLOBE NEWSWIRE) — (NASDAQ GS: HBNC) – Horizon Bancorp, Inc. (“Horizon” or the “Company”) announced today that John R. Stewart, CFA has been named Horizon’s next Executive Vice President and Chief Financial Officer (CFO). Stewart will assume the responsibilities of CFO on May 20, 2024. Stewart has 22 years of financial services experience spanning banking, investment management and corporate finance at regional banks, global investment banks and institutional asset management firms. He has held leadership roles in both public and private financial institutions with his most recent role as the Deputy Chief Financial Officer of a $30 billion publicly traded bank with oversight responsibilities for several lines of business and previously included all finance functions including corporate treasury,...

Continue reading

Glacier Reports First Quarter 2024 Results

VANCOUVER, British Columbia, May 13, 2024 (GLOBE NEWSWIRE) — Glacier Media Inc. (TSX: GVC) (“Glacier” or the “Company”) reported revenue and earnings for the period ended March 31, 2024. SUMMARY RESULTS(thousands of dollars)   Three months ended March 31,  except share and per share amounts     2024       2023           Revenue   $ 34,750     $ 39,218  EBITDA (1)   $ (322 )   $ (2,241 )EBITDA (1) margin     (0.9 %)     (5.7 %)EBITDA (1) per share   $ (0.00 )   $ (0.02 )Capital expenditures   $ 759     $ 1,077  Net loss attributable to common shareholder   $ (4,429 )   $ (5,217 )Net loss attributable to common shareholder per share   $ (0.03 )   $ (0.04 )         Weighted average shares outstanding, net     131,131,598       132,329,984           (1)  EBITDA is considered a non-GAAP measure....

Continue reading

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update

Company hosting in-person R&D day event, focused on atrioventricular interval modulation (“AVIM”) therapy, including the unmet need in hypertension, mechanism of action, clinical results and design of the BACKBEAT study in New York City on June 11, 2024NEW HOPE, Pa., May 13, 2024 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its first quarter 2024 financial results and provided a business update. “Since initiating patient enrollment of the BACKBEAT global pivotal study, our team has been hard at work alongside our colleagues at Medtronic to activate study sites and support patient enrollment in the U.S. and EU,” commented David Hochman,...

Continue reading

Maui Land & Pineapple Company Reports Fiscal 2024 First Quarter Results

Annual Meeting and Shareholder Presentation to be held virtually on May 15, 2024 at 10:00 a.m. HST KAPALUA, Hawaii, May 13, 2024 (GLOBE NEWSWIRE) — Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results covering the three month period ended March 31, 2024. The company’s annual meeting and shareholder presentation will be held virtually on May 15, 2024 at 10:00 a.m. Hawaii Standard Time, via meeting link posted on mauiland.com/investors. “Maui Land & Pineapple Company’s renewed mission to maximize the productive use of our diverse portfolio of land and commercial properties is starting to yield tangible results,” said CEO Race Randle. “Despite the challenges following the 2023 Maui wildfires, concerted efforts to reposition and increase occupancy at the Kapalua Village and Hali‘imaile Town Centers...

Continue reading

Astrotech Reports Third Quarter of Fiscal Year 2024 Financial Results

AUSTIN, Texas, May 13, 2024 (GLOBE NEWSWIRE) — Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2024, which ended March 31, 2024. Financial Highlights & Recent Developments Astrotech’s consolidated balance sheet remains strong with $34.7 million in cash and liquid investments. Year-to-date revenue totaled $1.6 million and was generated by sales of TRACER 1000™ explosive trace detector (ETD), as well as recurring maintenance services and sales of consumables for the TRACER 1000. The increase in revenue from the prior fiscal year is primarily the result of new unit sales of the TRACER 1000, fulfilling both of the previously announced purchase orders received. Year-to-date gross margin increased to 45% from 37% through the third quarter...

Continue reading

Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update

Strong financial position with $157.3 million; runway into 2H 2026 IK-930 program on track to deliver clinical update in 2H 2024 IK-595 program continues dose escalation in patients with RAS and RAF mutant cancers BOSTON, May 13, 2024 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” “Company”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced financial results for the first quarter ended March 31, 2024. The Company also provided an update regarding its organization and pipeline. “We continue to execute thoughtfully and diligently on our clinical programs,” said Mark Manfredi, Ph.D., Chief Executive Officer of Ikena. “With the dedication of our hyper-focused team and strong balance sheet, we are well positioned to build value for our shareholders...

Continue reading

Bridger Aerospace Announces First Quarter 2024 Results

Earliest Seasonal Deployment Positions the Company for Record Growth BELGRADE, Mont., May 13, 2024 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today reported results for the first quarter ended March 31, 2024. The Company also reiterated its 2024 revenue and adjusted EBITDA guidance supported by the earliest seasonal deployment in company history. Highlights:Earliest seasonal deployment of Super Scooper and surveillance aircraft in company history leads to highest first quarter revenue and positions the company for another record year Completed a $9.8 million equity financing in April 2024 with participation and support from existing investors as well as members of the management team...

Continue reading

Shimmick Corporation Announces First Quarter 2024 Results

IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) — Shimmick Corp. (NASDAQ: SHIM), a leading water infrastructure company, today announced financial results for the first quarter ended March 29, 2024. First Quarter 2024 and Recent HighlightsReported revenue of $120 million, which includes $90 million of Shimmick Projects revenue Reported a net loss of $33 million with an Adjusted EBITDA loss of $24 million Continue to work down legacy backlog with revenue of $23 million, a decline from $56 million last year with a negative gross margin of $11 million, reflecting increases in the estimated cost to complete and ongoing legal costs Announced the sale of the assets related to non-core foundation drilling projects and an equipment yard that will raise approximately $39 million and reduce future capital expenditures Backlog is over $1.0...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.